Variation in step therapy for commercial plan coverage of rheumatoid arthritis therapies

Date: October 16, 2026

Journal: AMCP Nexus 2026

Citation: Brennan C, Chambers J. Variation in step therapy for commercial plan coverage of rheumatoid arthritis therapies. Poster presented at: AMCP Nexus. October 2026. San Diego, CA.

Download Poster

More Publications

Do prices and doses differ for initial and follow-on indications? An analysis of multi-indication orphan drugs

View Publication

Can Real-World Evidence Reliably Fill Evidence Gaps In Accelerated Approval?

View Publication

US Commercial Health Plan Step-Therapy Requirements for Ranibizumab Products, 2017–2025

View Publication

View All Publications